Luca Issi
Stock Analyst at RBC Capital
(1.56)
# 3,433
Out of 4,509 analysts
667
Total ratings
41.4%
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintained: Buy | $100 → $85 | $56.78 | +49.70% | 40 | Jul 13, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $445 | $280.23 | +58.80% | 64 | Jul 7, 2026 | |
| AMGN Amgen | Maintained: Buy | $370 | $357.00 | +3.64% | 11 | Jul 7, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Hold | $66 → $62 | $58.86 | +5.33% | 36 | Jul 7, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Hold | $28 → $32 | $40.06 | -20.12% | 7 | Jul 7, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $35 → $40 | $31.90 | +25.39% | 19 | Jul 7, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $275 → $280 | $263.72 | +6.17% | 16 | Jul 7, 2026 | |
| ARGX argenx SE | Maintained: Buy | $890 → $945 | $856.94 | +10.28% | 11 | Jul 7, 2026 | |
| MRNA Moderna | Maintained: Hold | $38 → $45 | $68.21 | -34.03% | 38 | Jul 7, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $100 | $82.94 | +20.57% | 3 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $65 | $40.89 | +58.98% | 43 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $4 | $3.43 | +16.62% | 6 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $765.00 | - | 1 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $0.0899 | +2,124.69% | 21 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $12.82 | +48.21% | 39 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.89 | +376.19% | 32 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 | $13.16 | +13.98% | 36 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $23.05 | +30.15% | 11 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $4.71 | +324.63% | 14 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $13.99 | -42.82% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 | $31.06 | -16.29% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.82 | +449.45% | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $87 | $73.44 | +18.46% | 38 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $3.12 | +28.21% | 26 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 | $51.39 | -2.70% | 29 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $6.13 | +144.70% | 27 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $11 | $12.81 | n/a | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $54 | $18.30 | n/a | 13 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $5.38 | n/a | 7 | Mar 21, 2023 |
Ionis Pharmaceuticals
Jul 13, 2026
Maintained: Buy
Price Target: $100 → $85
Current: $56.78
Upside: +49.70%
Alnylam Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $445
Current: $280.23
Upside: +58.80%
Amgen
Jul 7, 2026
Maintained: Buy
Price Target: $370
Current: $357.00
Upside: +3.64%
BioMarin Pharmaceutical
Jul 7, 2026
Maintained: Hold
Price Target: $66 → $62
Current: $58.86
Upside: +5.33%
Agios Pharmaceuticals
Jul 7, 2026
Maintained: Hold
Price Target: $28 → $32
Current: $40.06
Upside: -20.12%
Ultragenyx Pharmaceutical
Jul 7, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $31.90
Upside: +25.39%
Ascendis Pharma
Jul 7, 2026
Maintained: Buy
Price Target: $275 → $280
Current: $263.72
Upside: +6.17%
argenx SE
Jul 7, 2026
Maintained: Buy
Price Target: $890 → $945
Current: $856.94
Upside: +10.28%
Moderna
Jul 7, 2026
Maintained: Hold
Price Target: $38 → $45
Current: $68.21
Upside: -34.03%
BridgeBio Pharma
Jul 7, 2026
Maintained: Buy
Price Target: $100
Current: $82.94
Upside: +20.57%
Jun 18, 2026
Maintained: Buy
Price Target: $35 → $65
Current: $40.89
Upside: +58.98%
Jun 2, 2026
Maintained: Hold
Price Target: $10 → $4
Current: $3.43
Upside: +16.62%
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $765.00
Upside: -
May 14, 2026
Maintained: Hold
Price Target: $2
Current: $0.0899
Upside: +2,124.69%
May 14, 2026
Maintained: Buy
Price Target: $19
Current: $12.82
Upside: +48.21%
May 13, 2026
Maintained: Buy
Price Target: $9
Current: $1.89
Upside: +376.19%
May 11, 2026
Maintained: Hold
Price Target: $15
Current: $13.16
Upside: +13.98%
May 11, 2026
Reiterated: Buy
Price Target: $30
Current: $23.05
Upside: +30.15%
May 11, 2026
Maintained: Buy
Price Target: $20
Current: $4.71
Upside: +324.63%
May 8, 2026
Maintained: Hold
Price Target: $8
Current: $13.99
Upside: -42.82%
May 8, 2026
Maintained: Hold
Price Target: $26
Current: $31.06
Upside: -16.29%
May 8, 2026
Maintained: Buy
Price Target: $10
Current: $1.82
Upside: +449.45%
May 7, 2026
Maintained: Buy
Price Target: $80 → $87
Current: $73.44
Upside: +18.46%
May 5, 2026
Maintained: Hold
Price Target: $4
Current: $3.12
Upside: +28.21%
May 4, 2026
Maintained: Hold
Price Target: $50
Current: $51.39
Upside: -2.70%
Apr 28, 2026
Maintained: Buy
Price Target: $15
Current: $6.13
Upside: +144.70%
Nov 13, 2024
Maintained: Buy
Price Target: $9 → $11
Current: $12.81
Upside: n/a
May 11, 2023
Maintained: Hold
Price Target: $3 → $54
Current: $18.30
Upside: n/a
Mar 21, 2023
Maintained: Hold
Price Target: $4 → $3
Current: $5.38
Upside: n/a